| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H31N |
| Molecular Weight | 285.4668 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC3=CC(=CC=C3[C@@]1(C)CCC[C@@]2(C)CN)C(C)C
InChI
InChIKey=JVVXZOOGOGPDRZ-SLFFLAALSA-N
InChI=1S/C20H31N/c1-14(2)15-6-8-17-16(12-15)7-9-18-19(3,13-21)10-5-11-20(17,18)4/h6,8,12,14,18H,5,7,9-11,13,21H2,1-4H3/t18-,19-,20+/m0/s1
| Molecular Formula | C20H31N |
| Molecular Weight | 285.4668 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 2.9 µM [Ki] | |||
| 9.5 µM [IC50] | |||
| 9.5 µM [IC50] | |||
| 2.9 µM [Ki] |
|
|
SALT/SOLVATE -> PARENT |
Showing 1 to 1 of 1 entries